Assaf Harofeh

Rishon LeZiyyon 75141

0 studies enrolling now · 3 studies all time

What they study most

First Line Non-Small Cell Lung Cancer, Ulcerative Colitis

Studies at this site

• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors — Completed